Microsoft Corp. has announced it has signed a joint marketing agreement with SAP America Inc., a subsidiary of SAP AG, through which the companies have agreed to work together to deliver solutions that meet the unique needs of the healthcare industry.
Quest Diagnostics recently announced that its wholly-owned subsidiary Quest Diagnostics India has signed a long-term agreement to provide health assessment services, including diagnostic laboratory testing for Birla Sun Life Insurance Company.
[This article was published in the January 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ]
GE Healthcare, the US$17 billion healthcare business of General Electric Company (NYSE: GE) has announced the signing of a contract between the Government of Madhya Pradesh, GE Healthcare and Sanya Hospitals and Diagnostic center
A pharma packaging company Bilcare Research of Pune has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and fingerprinting.
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
The Comptroller and Auditor-General of India (CAG) has indicted the Union Health Ministry for
Indian pharmaceutical major Dr Reddy
Thermo Fisher Scientific Inc. , the world leader in serving science, today announced it has broken ground on a new USD 17 million facility in Ahmadabad, India, to support growing demand for biopharma services in that country.
Pfizer Inc and Sermo, the largest online physician community in the US, have announced a strategic collaboration designed to redefine the way physicians in the U.S. and the healthcare industry work together to improve patient care.
Given the vast number of workers to be covered, the new Health Insurance Scheme (HIS) would be implemented in a phased manner. Initially workers living Below the Poverty Line (BPL) are to be covered in next five years.
The European Parliament will be demanding for funds to creation of a generic drugs industry in poor countries as the long-term solution to the developing world’s health crisis.
